MyBlueDots

Targeted centrosome inheritance during CD8⁺ T cell division plays role in memory precursor cell generation: Study

MyBlueDots4 weeks ago01 mins

A recent Cell Reports paper by the Oxenius group (IMB) demonstrates a function of targeted centrosome inheritance during CD8+ T cell division for the generation of memory precursor cells.

Clinical trial shows ‘Shared Care’ model safe for patients after donor stem cell transplant

MyBlueDots4 weeks ago01 mins

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized follow-up care, traditionally delivered at the center where they received their transplant—often a serious challenge for those who live far away. A large clinical trial by Dana-Farber Cancer Institute investigators shows that patients can fare just as well when they receive some of this care at a local hematology/oncology clinic.

RNA’s influence on sugar metabolism could transform gut health strategies

MyBlueDots4 weeks ago01 mins

Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a protein and a group of small ribonucleic acids (sRNAs) in Bacteroides thetaiotaomicron, which regulate sugar metabolism. These discoveries shed light on how this gut microbe adapts to varying nutritional conditions.

High-fat diet during adolescence increases impulsive behaviors in adult rodents

MyBlueDots4 weeks ago01 mins

For adults, a diet high in saturated fats and added sugar has been linked to impulsivity and poor self-control. But what role, if any, does diet play in adolescent psychological development?

Combination treatment for liver cancer significantly improves progression-free survival in global trial

MyBlueDots4 weeks ago01 mins

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC). This research, led by Josep M. Llovet, MD, Ph.D., Professor of Medicine (Liver Diseases) at the Icahn School of Medicine at Mount Sinai, tested a combination of treatments that could help patients live longer without their cancer getting worse.

Drug resistance study reveals mechanisms that enable lung cancer recurrence

MyBlueDots4 weeks ago01 mins

A recent study uncovers how drug-resistant cancer cells induce changes in the tumor microenvironment. This phenomenon promotes cancer recurrence and explains why initially effective targeted therapies can lose their efficacy over time. The research is published in the journal Nature Communications.

MyBlueDots

BPGbio's Lipidomics Expertise Powers Groundbreaking Discovery of Lipid-Rich Cartilage Published in Science

MyBlueDots4 weeks ago01 mins

BOSTON–(BUSINESS WIRE)– #bpgbio–BPGbio’s lipidomics expertise powers groundbreaking discovery of lipid-rich cartilage published in Science.

MyBlueDots

PURE Bioscience Unveils New Brand Identity

MyBlueDots4 weeks ago01 mins

EL CAJON, Calif.–(BUSINESS WIRE)– #Antimicrobial–PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and branded by Greenville (“bbG”), is excited to announce the official start of an extensive rebranding campaign to renew its corporate vision. This rebranding initiative aims to strengthen the Company’s identity and culture in the market and to better reflect its commitment to cutting-edge scientific advancement

Semaglutide currently not cost-effective for heart patients without diabetes, study finds

MyBlueDots4 weeks ago01 mins

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows. However, with price reductions or rebates up to 50%, it could meet the benchmark for value in health care.

Scientists reveal genetic drivers of metastasis across multiple cancer types

MyBlueDots4 weeks ago01 mins

Cancer metastasis—the spread of cancer to other organs—is the leading cause of death among cancer patients. Researchers have now uncovered a “genetic signature” of 177 genes shared across multiple cancer types that drives this deadly process.

Useful _Links

Generally, things really do seem better in the morning, large study suggests

GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds

Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics

‘Good’ cholesterol may be linked to heightened glaucoma risk among over 55s

New insights into liver maturation and specialization could advance regenerative medicine

Research shows positive changes in opioid prescribing, but trend among young people a cause for concern

Targeted centrosome inheritance during CD8⁺ T cell division plays role in memory precursor cell generation: Study

Clinical trial shows ‘Shared Care’ model safe for patients after donor stem cell transplant

RNA’s influence on sugar metabolism could transform gut health strategies

High-fat diet during adolescence increases impulsive behaviors in adult rodents

Combination treatment for liver cancer significantly improves progression-free survival in global trial

Drug resistance study reveals mechanisms that enable lung cancer recurrence

BPGbio's Lipidomics Expertise Powers Groundbreaking Discovery of Lipid-Rich Cartilage Published in Science

PURE Bioscience Unveils New Brand Identity

Semaglutide currently not cost-effective for heart patients without diabetes, study finds

Scientists reveal genetic drivers of metastasis across multiple cancer types

World News

Useful Links

Health

Business

Entertainment

About Us